Profile data is unavailable for this security.
About the company
Sanofi India Limited is an India-based company, which is engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company produces pharmaceutical formulations, dosage forms and offer a range of medicines across various therapeutic areas. Its product portfolio is focused on five therapeutic areas: diabetes, epilepsy, cardiology, allergy and pain care. In the diabetes area, the Company has an insulin portfolio under the brand name of Lantus, which helps in controlling high blood sugar in adults and children with diabetes mellitus. It also provides Toustar pen, along with dedicated Toujeo cartridges, addressing the need for a reusable delivery device. Combiflam, its product, helps to reduce pain and inflammation in conditions like headache, muscle and joint pain, and also reduces fever. Its brands also include Cardace, Allegra, Avil and Frisium. The Company has its own manufacturing facility in Goa. It has around 12 contract manufacturing organizations.
- Revenue in INR (TTM)18.37bn
- Net income in INR3.27bn
- Incorporated1956
- Employees991.00
- LocationSanofi India Ltd54/ASir Mathuradas Vasanji RoadAndheri EastMUMBAI 400072IndiaIND
- Phone+91 2 228032000
- Fax+91 2 228032846
- Websitehttps://www.sanofi.com/en/india
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| F D C Ltd | 20.78bn | 2.17bn | 58.96bn | 6.86k | 27.21 | -- | 21.27 | 2.84 | 13.31 | 13.31 | 127.73 | -- | -- | -- | -- | 3,030,531.00 | -- | 11.35 | -- | 12.96 | 67.92 | 60.85 | 10.43 | 14.75 | -- | 47.92 | -- | 6.34 | 8.50 | 9.42 | -12.59 | 2.15 | 25.37 | -- |
| Aarti Pharmalabs Ltd | 18.01bn | 2.14bn | 63.47bn | 2.16k | 29.69 | -- | 20.30 | 3.53 | 23.58 | 23.58 | 200.27 | -- | -- | -- | -- | 8,324,436.00 | -- | -- | -- | -- | 53.87 | -- | 11.87 | -- | -- | 9.34 | -- | -- | 14.17 | -- | 25.59 | -- | -- | -- |
| Shilpa Medicare Ltd | 14.32bn | 1.50bn | 65.15bn | 898.00 | 42.97 | -- | 24.31 | 4.55 | 7.75 | 7.75 | 73.87 | -- | -- | -- | -- | 15,945,910.00 | -- | 2.02 | -- | 2.61 | 70.47 | 60.07 | 10.48 | 5.17 | -- | 4.67 | -- | 9.89 | 11.71 | 7.22 | 145.63 | -12.90 | 16.09 | -- |
| Sudeep Pharma Ltd | 6.17bn | 1.68bn | 65.88bn | -- | 38.27 | -- | 35.86 | 10.68 | 15.24 | 15.24 | 55.94 | -- | -- | -- | -- | -- | -- | -- | -- | -- | 63.01 | -- | 27.56 | -- | -- | 55.99 | -- | -- | 9.40 | -- | 4.19 | -- | -- | -- |
| Blue Jet Healthcare Ltd | 10.53bn | 2.94bn | 66.84bn | 491.00 | 22.75 | -- | 21.15 | 6.35 | 16.93 | 16.93 | 60.76 | -- | -- | -- | -- | 21,448,020.00 | -- | -- | -- | -- | 53.75 | -- | 27.88 | -- | -- | 59.81 | -- | -- | 44.74 | -- | 86.38 | -- | -- | -- |
| Akums Drugs and Pharmaceuticals Ltd | 42.57bn | 3.18bn | 72.62bn | 7.54k | 22.83 | -- | 15.16 | 1.71 | 20.78 | 20.78 | 277.93 | -- | -- | -- | -- | 5,648,482.00 | -- | -- | -- | -- | 41.45 | -- | 7.63 | -- | -- | 4.15 | -- | -- | -1.44 | -- | 8,481.07 | -- | -- | -- |
| Jeena Sikho Lifecare Ltd | -100.00bn | -100.00bn | 75.20bn | 3.76k | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | -- | 32.29 | -- | 40.74 | -- | 92.07 | -- | 16.78 | -- | -- | -- | -- | 44.59 | 37.80 | 31.10 | 73.77 | 47.62 | -- |
| Marksans Pharma Ltd | 28.03bn | 3.60bn | 77.51bn | 1.35k | 21.49 | -- | 16.89 | 2.77 | 7.96 | 7.96 | 61.92 | -- | -- | -- | -- | 20,780,450.00 | -- | 14.15 | -- | 17.41 | 56.77 | 51.56 | 12.90 | 14.58 | -- | 20.42 | -- | 7.77 | 20.46 | 18.25 | 21.32 | 26.60 | 23.73 | 51.57 |
| Strides Pharma Science Ltd | 47.26bn | 5.11bn | 79.72bn | 3.30k | 15.59 | -- | 10.95 | 1.69 | 55.49 | 55.49 | 512.73 | -- | -- | -- | -- | 14,315,680.00 | -- | -0.6014 | -- | -1.09 | 59.34 | 50.33 | 11.23 | -1.06 | -- | 8.50 | -- | -- | 17.36 | 10.65 | 437.22 | 52.50 | 10.08 | -22.16 |
| Procter & Gamble Health Ltd | 13.49bn | 2.93bn | 81.13bn | 1.33k | 27.67 | -- | 25.65 | 6.02 | 176.64 | 176.64 | 811.45 | -- | -- | -- | -- | 10,169,760.00 | -- | -- | -- | -- | 72.49 | -- | 21.76 | -- | -- | 806.81 | -- | -- | -- | -- | -- | -- | -- | -- |
| Sanofi India Ltd | 18.37bn | 3.27bn | 87.14bn | 991.00 | 26.67 | 11.63 | 23.94 | 4.74 | 141.85 | 141.85 | 797.77 | 325.31 | 1.28 | 2.20 | 9.04 | -- | 22.79 | 24.37 | 39.46 | 36.22 | 51.17 | 53.29 | 17.78 | 22.21 | 0.9951 | 267.06 | 0.0232 | 70.08 | -8.73 | -8.74 | 4.14 | -7.31 | -9.10 | -0.3221 |
| Viyash Scientific Ltd | 21.26bn | 768.08m | 88.54bn | 1.24k | 85.46 | -- | 43.98 | 4.17 | 2.37 | 2.37 | 70.40 | -- | -- | -- | -- | 17,086,170.00 | -- | 0.4014 | -- | 0.6553 | 51.15 | 42.16 | 4.52 | 0.4199 | -- | 3.92 | -- | 995.91 | 13.26 | 5.64 | 160.99 | -20.73 | -0.126 | -- |
| Corona Remedies Ltd | 13.44bn | 1.71bn | 96.72bn | 4.57k | 56.45 | -- | 46.29 | 7.20 | 28.01 | 28.01 | 219.70 | -- | -- | -- | -- | 2,980,876.00 | -- | -- | -- | -- | 81.28 | -- | 12.75 | -- | -- | 55.10 | -- | -- | 17.93 | -- | 65.11 | -- | -- | -- |
| Sanofi Consumer Healthcare India Ltd | 8.78bn | 2.40bn | 101.57bn | 583.00 | 42.30 | 26.45 | 40.34 | 11.56 | 104.25 | 104.25 | 381.40 | 166.73 | 1.80 | 4.48 | 40.57 | -- | 49.09 | -- | 66.76 | -- | 73.80 | -- | 27.33 | -- | 3.37 | 148.65 | 0.0607 | -- | 21.24 | -- | 32.65 | -- | -- | -- |
| Cohance Lifesciences Ltd | 20.51bn | 2.02bn | 107.08bn | 1.21k | 48.25 | -- | 31.18 | 5.22 | 5.80 | 5.80 | 58.32 | -- | -- | -- | -- | 16,926,160.00 | -- | 18.62 | -- | 20.90 | 71.62 | 60.82 | 8.80 | 30.28 | -- | 7.07 | -- | 15.59 | 13.91 | 7.51 | -10.79 | -3.31 | 9.39 | -- |
| Alivus Life Sciences Ltd | 25.12bn | 5.44bn | 112.31bn | 2.20k | 20.69 | -- | 18.27 | 4.47 | 44.23 | 44.23 | 204.37 | -- | -- | -- | -- | 11,403,810.00 | -- | 17.43 | -- | 23.95 | 57.08 | 53.29 | 21.64 | 20.24 | -- | 133.39 | -- | 27.09 | 4.54 | 9.20 | 3.13 | 9.18 | 26.57 | -- |
Data as of Mar 06 2026. Currency figures normalised to Sanofi India Ltd's reporting currency: Indian Rupee INR
20.44%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Life Insurance Corporation of India (Investment Portfolio)as of 30 Sep 2025 | 1.37m | 5.95% |
| Nippon Life India Asset Management Ltd. (Invt Mgmt)as of 31 Jan 2026 | 872.51k | 3.79% |
| Aditya Birla Sun Life Amc Ltd. (Investment Management)as of 31 Jan 2026 | 550.00k | 2.39% |
| SBI Funds Management Ltd.as of 31 Jan 2026 | 528.14k | 2.29% |
| The Vanguard Group, Inc.as of 04 Feb 2026 | 372.29k | 1.62% |
| HDFC Life Insurance Co. Ltd. (Investment Portfolio)as of 30 Sep 2025 | 338.76k | 1.47% |
| Bajaj Allianz Life Insurance Co. Ltd.as of 30 Sep 2025 | 316.46k | 1.37% |
| BlackRock Fund Advisorsas of 06 Feb 2026 | 143.80k | 0.62% |
| Dimensional Fund Advisors LPas of 05 Feb 2026 | 126.31k | 0.55% |
| Norges Bank Investment Managementas of 31 Dec 2025 | 89.89k | 0.39% |
More ▼
Data from 31 Dec 2025 - 04 Mar 2026Source: FactSet Research Systems Inc.
